Clinical Trial

Quantitative Assessment of Signal Loss in Cardiotocography Using External Recording

Study acronym: RCFLoS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 2, 2025 (before its estimated December 22, 2025 completion). Its status may not reflect the trial's current state.
Summary
Signal loss in cardiotocography (CTG) recordings is numerous and frequent, whether due to artifacts in signal acquisition or confusion over inadvertent maternal heart rate recording, with various negative consequences for neonatal morbidity and unnecessary obstetric interventions. Data on this issue are 10 to 15 years old. CTG remains the primary method for assessing fetal well-being during labor, almost systematically.
Trial Details
NCT Number NCT06906744
Lead Sponsor University Hospital, Strasbourg, France
Conditions Maternal Heart Rate
Enrollment 500 participants
Start Date 2024-02-22
Primary Completion 2025-12-22 (estimated)
Study Completion 2025-12-22 (estimated)
Updated on ClinicalTrials.gov 2025-04-02